Literature DB >> 3005646

Characterization and mapping of a nonessential pseudorabies virus glycoprotein.

M W Wathen, L M Wathen.   

Abstract

Antigenic variants of pseudorabies virus (PRV) containing mutations in a viral glycoprotein with a molecular weight of 82,000 (gIII) were isolated by selecting for resistance to a complement-dependent neutralizing monoclonal antibody (MCA82-2) directed against gIII. These mutants were completely resistant to neutralization with MCA82-2 in the presence of complement. Two mutants selected for further studies either did not express gIII or expressed an improperly processed form of the glycoprotein. The mutations were also associated with an altered plaque morphology (syncytium formation). The gIII gene was mapped by marker rescue of a gIII- mutant with cloned restriction enzyme fragments to the long unique region of the PRV genome between 0.376 and 0.383 map units. This corresponds to the map location of a glycoprotein described by Robbins et al. (J. Mol. Appl. Gen. 2:485-496, 1984). Since gIII is nonessential for viral replication in cell culture and has several other characteristics in common with the herpes simplex virus glycoprotein gC, gIII may represent the PRV equivalent to herpes simplex virus gC.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005646      PMCID: PMC252890     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

2.  Gene transfer: DNA microinjection compared with DNA transfection with a very high efficiency.

Authors:  Y M Shen; R R Hirschhorn; W E Mercer; E Surmacz; Y Tsutsui; K J Soprano; R Baserga
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

3.  Physical mapping of the mutation in an antigenic variant of herpes simplex virus type 1 by use of an immunoreactive plaque assay.

Authors:  T C Holland; R M Sandri-Goldin; L E Holland; S D Marlin; M Levine; J C Glorioso
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

4.  Synthesis of proteins in cells infected with herpesvirus. V. Viral glycoproteins.

Authors:  T Ben-Porat; A S Kaplan
Journal:  Virology       Date:  1970-06       Impact factor: 3.616

5.  Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity.

Authors:  J Glorioso; C H Schröder; G Kumel; M Szczesiul; M Levine
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

6.  Mapping of the structural gene for the herpes simplex virus type 2 counterpart of herpes simplex virus type 1 glycoprotein C and identification of a type 2 mutant which does not express this glycoprotein.

Authors:  K M Zezulak; P G Spear
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

7.  Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies.

Authors:  T C Holland; S D Marlin; M Levine; J Glorioso
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

8.  Cell-mediated immunity to herpes simplex virus: recognition of type-specific and type-common surface antigens by cytotoxic T cell populations.

Authors:  R Eberle; R G Russell; B T Rouse
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

9.  Structure of varicella-zoster virus DNA.

Authors:  S E Straus; H S Aulakh; W T Ruyechan; J Hay; T A Casey; G F Vande Woude; J Owens; H A Smith
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

10.  Relative titers of antibodies to individual polypeptide antigens of herpes simplex virus type 1 in human sera.

Authors:  R Eberle; S W Mou
Journal:  J Infect Dis       Date:  1983-09       Impact factor: 5.226

View more
  19 in total

1.  Correlation between gI, gII, gIII, and gp 50 antibodies and virus excretion in vaccinated pigs infected with pseudorabies virus.

Authors:  M Eloit; P Vannier; E Hutet; A Fournier
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  The gIII glycoprotein of pseudorabies virus is involved in two distinct steps of virus attachment.

Authors:  L Zsak; N Sugg; T Ben-Porat; A K Robbins; M E Whealy; L W Enquist
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Antigenic variation of pseudorabies virus glycoproteins g II and g III demonstrated by neutralizing monoclonal antibodies.

Authors:  S Yamada; T Imada; T Nishimori; K Sekikawa; M Shimizu
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Attenuated live vaccine (Bartha-K16) caused pseudorabies (Aujeszky's disease) in sheep.

Authors:  Hanjin Kong; Keshan Zhang; Yongjie Liu; Youjun Shang; Bin Wu; Xiangtao Liu
Journal:  Vet Res Commun       Date:  2013-06-25       Impact factor: 2.459

5.  Release of pseudorabies virus from infected cells is controlled by several viral functions and is modulated by cellular components.

Authors:  L Zsak; T C Mettenleiter; N Sugg; T Ben-Porat
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

6.  Fine mapping of the immediate-early gene of the Indiana-Funkhauser strain of pseudorabies virus.

Authors:  A K Cheung
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

7.  The porcine humoral immune response against pseudorabies virus specifically targets attachment sites on glycoprotein gC.

Authors:  B T Ober; B Teufel; K H Wiesmüller; G Jung; E Pfaff; A Saalmüller; H J Rziha
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

8.  Complex between glycoproteins gI and gp63 of pseudorabies virus: its effect on virus replication.

Authors:  F A Zuckermann; T C Mettenleiter; C Schreurs; N Sugg; T Ben-Porat
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

9.  Role of glycoprotein gIII of pseudorabies virus in virulence.

Authors:  T C Mettenleiter; C Schreurs; F Zuckermann; T Ben-Porat; A S Kaplan
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  Cloning, sequencing, and functional characterization of the two subunits of the pseudorabies virus DNA polymerase holoenzyme: evidence for specificity of interaction.

Authors:  H Berthomme; S J Monahan; D S Parris; B Jacquemont; A L Epstein
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.